Cancer chemoprevention: Progress and perspectives

Current Drug Targets

Volumn 12, Issue 13, 2011, Pages 1871-1873

  Bonovas, Stefanos ^a  

^a Hellenic Centre for Disease Control and Prevention   (Greece)

Author keywords

Cancer chemoprevention; Clinical and experimental evidence

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICRORNA; PROSTAGLANDIN SYNTHASE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADVANCED CANCER; BREAST CANCER; BREAST CARCINOMA; CANCER MORTALITY; CANCER PREVENTION; CARDIOTOXICITY; CHEMOPROPHYLAXIS; COLON CARCINOMA; COLORECTAL CANCER; DIET THERAPY; DISEASE CONTROL; DNA METHYLATION; DRUG EFFICACY; EDITORIAL; EPIGENETICS; GENETIC PREDISPOSITION; HISTONE ACETYLATION; HUMAN; LUNG CARCINOMA; METHYLATION; NEOPLASM; PANCREAS CARCINOMA; PHASE 3 CLINICAL TRIAL (TOPIC); PROSTATE CARCINOMA; SYSTEMATIC REVIEW (TOPIC); TREATMENT FAILURE; ZANTHOXYLUM;

ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; NEOPLASMS;

EID: 82055208308     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945011798184137     Document Type: Editorial

References (20)

1. Garcia M, Jemal A, Ward EM, et al. Global Cancer Facts & Figures 2007. Atlanta, GA: American Cancer Society, 2007.
2. Boyle P, Levin B. World Cancer Report 2008. Lyon, France: International Agency for Research on Cancer, 2008.
3. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis 2010; 31: 100-10.
4. Bonovas S, Tsantes A, Drosos T, Sitaras NM. Cancer chemoprevention: a summary of the current evidence. Anticancer Res 2008; 28: 1857-66.
5. Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976; 36: 2699-702.
6. Sporn MB, Suh N. Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2002; 2: 537-43.
7. Sporn MB, Suh N. Chemoprevention of cancer. Carcinogenesis 2000; 21: 525-30.
8. Greenwald P. Cancer chemoprevention. BMJ 2002; 324: 714-8.
9. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994; 12: 851-73.
10. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1985; 45: 1-8.
11. Vogel VG. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention. Curr Drug Targets 2011; 12: 1874-87.
12. Moreira L, Castells A. Cyclooxygenase as a target for colorectal cancer chemoprevention. Curr Drug Targets 2011; 12: 1888-94.
13. Epifano F, Curini M, Marcotullio MC, Genovese S. Searching for novel cancer chemopreventive plants and their products: the genus Zanthoxylum. Curr Drug Targets 2011; 12: 1895-902.
14. Jacobs RJ, Kodach LL, Hardwick JCH. The potential of statins for individualized colorectal cancer chemoprevention. Curr Drug Targets 2011; 12: 1903-08.
15. Ferrari N, Tosetti F, De Flora S, Donatelli F, Noonan DM, Albini A. Diet-derived phytochemicals: from cancer chemoprevention to cardio-oncological prevention. Curr Drug Targets 2011; 12: 1909-24.
16. Huang J, Plass C, Gerhauser C. Cancer chemoprevention by targeting the epigenome. Curr Drug Targets 2011; 12: 1925-56.
17. Lollini PL, Nicoletti G, Landuzzi L, Cavallo F, Forni G, De Giovanni C, Nanni P. Vaccines and other immunological approaches for cancer immunoprevention. Curr Drug Targets 2011; 12: 1957-73.
18. Eccles DM. Development of genetic testing for breast, ovarian and colorectal cancer predisposition: a step closer to targeted cancer prevention. Curr Drug Targets 2011; 12: 1974-82.
19. Kelly RJ, Lopez-Chavez A, Szabo E. Criteria of evidence to move potential chemopreventive agents into late phase clinical trials. Curr Drug Targets 2011; 12: 1983-88.
20. Nikolopoulos GK, Bagos PG, Bonovas S. Developing the evidence base for cancer chemoprevention: use of meta-analysis. Curr Drug Targets 2011; 12: 1989-97.